Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS3598122 B1
Type de publicationOctroi
Date de publication23 nov. 1982
Date de dépôt1 avr. 1969
Date de priorité1 avr. 1969
Numéro de publicationUS 3598122 B1, US 3598122B1, US-B1-3598122, US3598122 B1, US3598122B1
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet

US 3598122 B1
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US3710795 *29 sept. 197016 janv. 1973Alza CorpDrug-delivery device with stretched, rate-controlling membrane
US3731683 *4 juin 19718 mai 1973Alza CorpBandage for the controlled metering of topical drugs to the skin
US3797494 *9 août 197119 mars 1974Alza CorpBandage for the administration of drug by controlled metering through microporous materials
US3807398 *19 sept. 197230 avr. 1974B GruczaOcular implant
US3854480 *2 juin 197017 déc. 1974Alza CorpDrug-delivery system
US3896819 *30 sept. 197129 juil. 1975Alza CorpIUD having a replenishing drug reservoir
US3951622 *4 déc. 197420 avr. 1976Wilk Immanuel JTime release perfume method and device
US3960150 *15 sept. 19751 juin 1976Alza CorporationBioerodible ocular device
US3961628 *21 avr. 19758 juin 1976Alza CorporationOcular drug dispensing system
US3964482 *17 mai 197122 juin 1976Alza CorporationDrug delivery device
US3981303 *31 juil. 197521 sept. 1976Alza CorporationBioerodible ocular device
US3986510 *1 août 197519 oct. 1976Alza CorporationBioerodible ocular device
US3993071 *24 juil. 197523 nov. 1976Alza CorporationBioerodible ocular device
US3993072 *17 oct. 197523 nov. 1976Alza CorporationMicroporous drug delivery device
US3993073 *3 mars 197523 nov. 1976Alza CorporationNovel drug delivery device
US3996934 *9 août 197114 déc. 1976Alza CorporationMedical bandage
US4191743 *2 nov. 19774 mars 1980Merck Patent Gesellschaft Mit Beschrankter HaftungAntibacterial wound dressing
US4201211 *12 juil. 19776 mai 1980Alza CorporationTherapeutic system for administering clonidine transdermally
US4286592 *4 févr. 19801 sept. 1981Alza CorporationTherapeutic system for administering drugs to the skin
US4336243 *4 mai 198122 juin 1982G. D. Searle & Co.Transdermal nitroglycerin pad
US4460371 *20 déc. 198217 juil. 1984Dennison Manufacturing CompanyMedical equipment for transdermal application
US4563184 *17 oct. 19837 janv. 1986Bernard KorolSynthetic resin wound dressing and method of treatment using same
US4568343 *9 oct. 19844 févr. 1986Alza CorporationSkin permeation enhancer compositions
US4594240 *7 sept. 198310 juin 1986Teikoku Seiyaku Kabushiki KaishaSheet-shape adhesive preparation
US4597961 *23 janv. 19851 juil. 1986Etscorn Frank TTranscutaneous application of nicotine
US4608249 *2 nov. 198226 août 1986Nitto Electric Industrial Co., Ltd.Carrier and drug containing patching layer
US4614787 *13 nov. 198430 sept. 1986Thermedics, Inc.Drug dispensing wound dressing
US4615697 *9 nov. 19847 oct. 1986Bio-Mimetics, Inc.Bioadhesive compositions and methods of treatment therewith
US4638043 *23 août 198520 janv. 1987Thermedics, Inc.Drug release system
US4649075 *9 août 198410 mars 1987Leonora JostTransdermal and transmucosal vortexed foam devices and the method of making
US4666441 *17 déc. 198519 mai 1987Ciba-Geigy CorporationMulticompartmentalized transdermal patches
US4704282 *29 juin 19843 nov. 1987Alza CorporationSustained release
US4719226 *31 déc. 198412 janv. 1988Nitto Electric Industrial Co., Ltd.Sustained drug release
US4725439 *13 janv. 198616 févr. 1988Alza CorporationReinforced matrix containing drug reservoir
US4727868 *20 mai 19871 mars 1988Thermedics, Inc.Anisotropic wound dressing
US4738848 *4 juin 198619 avr. 1988Nitto Electric Industrial Co., Ltd.Anti-inflammatory analgesic adhesive preparation
US4743249 *10 juin 198710 mai 1988Ciba-Geigy Corp.Dermal and transdermal patches having a discontinuous pattern adhesive layer
US4746515 *26 févr. 198724 mai 1988Alza CorporationSkin permeation enhancer compositions using glycerol monolaurate
US4751133 *11 mai 198714 juin 1988Thermedics, Inc.Medical patches and processes for producing same
US4752478 *17 déc. 198421 juin 1988Merck & Co., Inc.Transdermal system for timolol
US4764378 *10 févr. 198616 août 1988Zetachron, Inc.Matrices of high and low molecular weight polyoxyethylene glycols
US4764379 *24 août 198716 août 1988Alza CorporationTransdermal drug delivery device with dual permeation enhancers
US4767787 *24 mars 198630 août 1988Kaken Pharmaceutical Co., Ltd.Containing prostaglandin
US4769028 *17 juil. 19866 sept. 1988Lohmann Gmbh & Co. KgMultilayer with drug concentration gradient
US4781924 *9 nov. 19871 nov. 1988Alza CorporationRelease by moisture activator
US4788062 *26 févr. 198729 nov. 1988Alza CorporationDispersion in polymer matrix, permeation promoter
US4795436 *22 sept. 19863 janv. 1989Bio-Mimetics, Inc.Bioadhesive composition and method of treatment therewith
US4797284 *12 mars 198610 janv. 1989Merck & Co., Inc.Reservoir with permeable membrane
US4812305 *9 nov. 198714 mars 1989Vocal Rodolfo SWell medicine strip
US4816258 *26 févr. 198728 mars 1989Alza CorporationDrug delivery, ethylneestradiol, leyonorgestrel
US4820720 *29 mars 198811 avr. 1989Alza CorporationGlycerol monolaurate and ethanol enhancers;controlled drug delivery
US4834979 *14 déc. 198730 mai 1989Alza CorporationMedical bandage for administering beneficial drug
US4837027 *9 août 19886 juin 1989Alza CorporationTherapeutic agent stored as salt, moisture activates
US4839174 *5 oct. 198713 juin 1989Pharmetrix CorporationNovel transdermal nicotine patch
US4840796 *22 avr. 198820 juin 1989Dow Corning CorporationLinear thermoplastic polyurrethane polysiloxanne block coploym er
US4844903 *6 nov. 19874 juil. 1989Mepha AgProcess for the production of an adhesive plaster
US4863738 *23 nov. 19875 sept. 1989Alza CorporationTransdermal drug delivery
US4865848 *26 févr. 198712 sept. 1989Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4877618 *18 mars 198831 oct. 1989Reed Jr Fred DTransdermal drug delivery device
US4879275 *27 mai 19887 nov. 1989Nelson Research & Development Co.Penetration enhancers for transdermal delivery of systemic agent
US4880690 *9 sept. 198814 nov. 1989Thermedics, Inc.Perfume patch
US4885154 *1 mars 19885 déc. 1989Alza CorporationCoadministering a metabolic modulator
US4889720 *31 août 198726 déc. 1989Teikoku Seiyaku Kabushiki KaishaAdhesive, reservoir and control release layer
US4898592 *16 sept. 19886 févr. 1990Latzke Arno WMeans for the application of transdermally absorbable active substances
US4900552 *30 mars 198813 févr. 1990Watson Laboratories, Inc.Mucoadhesive buccal dosage forms
US4900555 *13 oct. 198813 févr. 1990Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4906475 *16 févr. 19886 mars 1990Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4908027 *12 sept. 198613 mars 1990Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US4909244 *26 nov. 198620 mars 1990The Kendall CompanyHydrogel wound dressing
US4917688 *27 juin 198817 avr. 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US4917895 *14 juil. 198817 avr. 1990Alza CorporationTransdermal drug delivery device
US4920101 *30 sept. 198724 avr. 1990Nelson Research & Development Co.For enhancing penetration of physiologically active agents through skin or other membranes
US4925671 *7 juil. 198415 mai 1990Flexcon Company, Inc.Polysiloxanes and nitroglycerin; transdermal
US4940586 *13 oct. 198810 juil. 1990Alza CorporationSkin permeation enhancer compositions using sucrose esters
US4942037 *2 juin 198817 juil. 1990Merck & Co., Inc.Transdermal delivery systems
US4943435 *28 oct. 198824 juil. 1990Pharmetrix CorporationTransdermal drug delivery, polyethylene membrane
US4951657 *22 avr. 198828 août 1990Dow Corning CorporationBlock copolymer of polyurethane and polysiloxane
US4956171 *21 juil. 198911 sept. 1990Paco Pharmaceutical Services, Inc.Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US4959208 *28 oct. 198825 sept. 1990Ppg Industries, Inc.Active agent delivery device
US4969871 *15 févr. 198913 nov. 1990Alza CorporationIntravenous system for delivering a beneficial agent
US4973468 *22 mars 198927 nov. 1990Cygnus Research CorporationSkin permeation enhancer compositions
US4979946 *7 avr. 198925 déc. 1990The Kendall CompanyEnvironmental absorbent dressing
US4985016 *15 févr. 198915 janv. 1991Alza CorporationIntravenous system for delivering a beneficial agent
US4994049 *15 nov. 198919 févr. 1991Latzke Arno WApplication of transdermally active oil; absorptive carrier on laminate support
US4997655 *22 juin 19885 mars 1991Biogal GyogyszergyarPharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
US5000956 *8 juil. 198819 mars 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5004610 *14 juin 19902 avr. 1991Alza CorporationSubsaturated nicotine transdermal therapeutic system
US5034386 *17 août 198823 juil. 1991Whitby Research, Inc.Fungicides
US5035886 *10 mai 199030 juil. 1991Ppg Industries, Inc.Active agent delivery device
US5045059 *15 août 19903 sept. 1991Alza CorporationIntravenous system for delivering a beneficial agent
US5049387 *9 juin 198917 sept. 1991Alza CorporationInducing skin tolerance to a sensitizing drug
US5053227 *12 juin 19901 oct. 1991Cygnus Therapeutic SystemsTransmittance of drug in mixture of diethylene glycol ethyl and/or methyl ether and ester
US5059189 *8 sept. 198722 oct. 1991E. R. Squibb & Sons, Inc.Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5059426 *12 juin 199022 oct. 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5068226 *30 avr. 199026 nov. 1991Cyclex, Inc.Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5071645 *20 mars 199110 déc. 1991Ppg Industries, Inc.Process of producing an active agent delivery device
US5071656 *14 nov. 198810 déc. 1991Alza CorporationNitroglycerin delivery to skin or mucosa
US5077054 *27 nov. 199031 déc. 1991Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5118509 *30 août 19912 juin 1992Alza CorporationInducing skin tolerance to a sensitizing drug
US5120545 *3 août 19909 juin 1992Alza CorporationSensitizing drug and antigen processing-inhibiting agent
US5124157 *18 août 198923 juin 1992Cygnus Therapeutic SystemsUsing adhesive skin patch
US5130139 *6 juil. 199014 juil. 1992Alza CorporationCoadministering lysosomac uptake inhibiting agent
US5141750 *14 nov. 198825 août 1992Alza CorporationDelayed onset transdermal delivery device
US5149539 *15 nov. 199122 sept. 1992Alza CorporationReduction or prevention of sensitization to drugs
US5160320 *14 févr. 19903 nov. 1992Alza CorporationIntravenous system for delivering a beneficial agent
US5160741 *13 nov. 19913 nov. 1992Alza CorporationReduction or prevention of skin irritation by drugs
US5171576 *30 août 199115 déc. 1992Alza CorporationPrevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5173302 *28 sept. 199022 déc. 1992Medtronic, Inc.2-acrylamido-2-methyl propanesulfonic acid copolymer, ethylene /propylene oxide derivative humectant, crosslinking monomer, initiator
US5189986 *23 sept. 19912 mars 1993Alza CorporationVeterinary transdermal active agent delivery device
US5196202 *2 oct. 198923 mars 1993Teikoku Seiyaku Kabushiki KaishaSustained release dosage form
US5198223 *9 mars 199230 mars 1993Alza CorporationEstrogen/Progesterone, Skin Permeation Enhancer
US5203768 *24 juil. 199120 avr. 1993Alza CorporationTransdermal delivery device
US5204339 *6 août 199020 avr. 1993Whitby Research, Inc.Penetration enhancers for transdermal delivery of systemic agents
US5217718 *17 sept. 19918 juin 1993Cygnus Therapeutic SystemsUsing pressure sensitive adhesive skin patch
US5223261 *31 déc. 199129 juin 1993Riker Laboratories, Inc.Transdermal estradiol delivery system
US5230896 *12 oct. 198927 juil. 1993Warner-Lambert CompanyTransdermal nicotine delivery system
US5234690 *23 août 199110 août 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5250028 *9 août 19915 oct. 1993Alza CorporationIntravenous system for delivering a beneficial agent using permeability enhancers
US5254346 *23 févr. 198919 oct. 1993Tucker Mark JOcclusive body for administering a physiologically active substance
US5268179 *14 févr. 19927 déc. 1993Ciba-Geigy CorporationUltrasonically sealed transdermal drug delivery systems
US5273755 *23 août 199128 déc. 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756 *23 août 199128 déc. 1993Cygnus Therapeutic SystemsA backing, a pressure-rupturable reservoir, adsorbent wick, drug-permeable polymer adhesive, an unplasticized microporous membrane, and a drug-permeable membrane
US5284660 *21 août 19928 févr. 1994Alza CorporationDelayed onset transdermal delivery device
US5286491 *18 mai 199215 févr. 1994Alza CorporationAdministering over a predetermined period of time
US5286748 *27 nov. 199115 févr. 1994Eby Iii George AAntirhinoviral medicine dispersed in sweet carrier as lozenge, troche or syrup
US5298257 *19 mars 199229 mars 1994Elan Transdermal LimitedControlled transdermal nicotine delivery; anti-irritant
US5304379 *3 nov. 199219 avr. 1994Alza CorporationA reservoir consists of tetracaine and metabolic modulator to inhibit monoamine oxidase enzyme
US5314694 *26 mars 199324 mai 1994Alza CorporationTransdermal formulations, methods and devices
US5320850 *12 févr. 199314 juin 1994Alza CorporationTransdermal delivery of the gestogen ST-1435 and devices therefor
US5322695 *25 août 199221 juin 1994Hercon Laboratories CorporationMoisture-vapor-permeable dressing
US5342623 *18 juin 199330 août 1994Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US5364628 *22 oct. 199315 nov. 1994Sandoz Ltd.Pharmaceutical compositions
US5364634 *8 nov. 199115 nov. 1994Southwest Research InstituteMouths; drug delivery
US5376377 *17 déc. 199227 déc. 1994Alza CorporationTransdermal contraceptive formulations, methods and devices
US5378730 *3 déc. 19923 janv. 1995Alza CorporationPermeation enhancer comprising ethanol and monoglycerides
US5402777 *3 juin 19924 avr. 1995Alza CorporationMethods and devices for facilitated non-invasive oxygen monitoring
US5411740 *8 févr. 19942 mai 1995Alza CorporationTransdermal administration of oxybutynin
US5445607 *15 oct. 199229 août 1995Theratech, Inc.Iontophoresis device and method using a rate-controlling electrically sensitive membrane
US5451407 *21 juin 199319 sept. 1995Alza CorporationReduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
US5464387 *27 oct. 19947 nov. 1995Alza CorporationTransdermal delivery device
US5490415 *15 avr. 199413 févr. 1996Pharmetrix CorporationDiffusion test apparatus and method
US5498417 *12 mai 199412 mars 1996Coating Sciences, Inc.Transdermal delivery of appetite suppressant drug
US5500222 *15 févr. 199519 mars 1996Alza CorporationMixed with monoglyceride permeation enhancer
US5508038 *16 avr. 199016 avr. 1996Alza CorporationDrug delivery patches having mixture of high and low molecular weight polymers as adhesives which dissolve active agents, free of plasticizers and tackifiers
US5508039 *16 oct. 199216 avr. 1996Alza CorporationControlled transdermal administration of melatonin
US5512292 *21 déc. 199430 avr. 1996Alza CorporationTransdermal contraceptive formulations methods and devices
US5536263 *30 mars 199416 juil. 1996Lectec CorporationPressure sensitive adhesive, hydrocolloidal gel matrix containing medication; sustained release
US5560922 *5 juin 19951 oct. 1996Rutgers, The State University Of New Jersey17-beta-estradiol skin patches; drug delivery
US5589192 *5 déc. 199431 déc. 1996Lintec CorporationGel pharmaceutical formulation for local anesthesia
US5599554 *19 mars 19964 févr. 1997The Procter & Gamble CompanyTreatment of nicotine craving and/or smoking withdrawal symptoms
US5633008 *12 août 199327 mai 1997Osborne; James L.Method of administering nicotine transdermally
US5633009 *12 nov. 199327 mai 1997Sano CorporationTransdermal administration of azapirones
US5641504 *20 mai 199224 juin 1997Alza CorporationTransdermal drug delivery
US5650165 *7 nov. 199522 juil. 1997Nitto Denko CorporationPercutaneous absorption preparation
US5662925 *26 avr. 19962 sept. 1997Theratech, Inc.For administering an active agent to the skin or mucosa of an individual
US5662928 *21 avr. 19952 sept. 1997Ciba-Geigy CorporationMethod for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US5691377 *14 juil. 199425 nov. 1997University Of Maryland Eastern Shore And University Of Maryland College ParkUse of N-methyl-aspartic acid for enhancing growth and altering body composition
US5705186 *5 janv. 19956 janv. 1998Lts Lohmann Therapie-Systeme GmbhPharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide
US5707663 *16 mai 199513 janv. 1998Alza CorporationSustained antiepileptic therapy
US5733255 *15 oct. 199631 mars 1998Novartis Finance CorporationThermopile powered transdermal drug delivery device
US5741510 *8 avr. 199621 avr. 1998Lectec CorporationAdhesive patch for applying analgesic medication to the skin
US5747065 *29 sept. 19945 mai 1998Lee; Eun SooMonoglyceride/lactate ester permeation enhancer for oxybutynin
US5750137 *29 sept. 199412 mai 1998Taskovich; Lina TormenDrug delivery, permeability, glycerides and lactates
US5763425 *8 janv. 19979 juin 1998Gundersen Clinic, Ltd.Gastrointestinal toxicity side effect inhibition
US5770220 *23 nov. 199423 juin 1998Lts Lohmann Therapie Systeme GmbhActive substance-containing patch
US5785991 *7 juin 199528 juil. 1998Alza CorporationTransdermal drug delivery
US5788983 *14 sept. 19924 août 1998Rutgers, The State University Of New JerseyTransdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5804214 *6 juil. 19948 sept. 1998Cygnus, Inc.Nonsteroidal antiinflammatory agents, analgesics
US5817331 *7 juin 19956 oct. 1998Sano CorporationAbsorption; drug delivery device
US5820876 *6 juin 199513 oct. 1998Lts Lohmann Therapie-Systeme Gmbh & Co. KgButadiene-acrylonitrile-methyl acrylate terpolymer, paper, and aluminum sealing bag containing a nicotine patch
US5837280 *7 juin 199517 nov. 1998Sano CorporationTransdermal administration of azapirones
US5840327 *15 août 199624 nov. 1998Alza CorporationTransdermal drug delivery device having enhanced adhesion
US5843468 *13 mai 19961 déc. 1998Alza CorporationSkin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5861170 *22 mars 199419 janv. 1999Lts Lohmann Therapie-Systeme Gmbh & Co. KgAcetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
US5882674 *3 juin 199516 mars 1999Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic system comprising active substances representing carbon monoxide sources
US5882676 *26 mai 199516 mars 1999Alza CorporationSkin permeation enhancer compositions using acyl lactylates
US5895660 *6 déc. 199420 avr. 1999Lts Lohmann Therapie-Systeme GmbhDeuterated active substances in transdermal application
US5900250 *30 avr. 19984 mai 1999Alza CorporationMonoglyceride/lactate ester permeation enhancer for oxybutnin
US5919478 *24 juin 19946 juil. 1999Alza CorporationIncorporating poly-N-vinyl amide in a transdermal system
US5942243 *12 mai 199824 août 1999Polytherapeutics, Inc.Mucoadhesive compositions for administration of biologically active agents to animal tissue
US5962011 *24 juin 19975 oct. 1999Schering-Plough Healthcare Products, Inc.The device is useful for treating lesions or abnormal skin features such as corns, warts, calluses, bunions, actinic keratoses and hard hyperkeratotic skin as is often found on the face, arms, legs or feet.
US5962013 *4 août 19985 oct. 1999Cygnus, Inc.Monolithic matrix transdermal delivery system for administering molsidomine
US5980943 *21 oct. 19979 nov. 1999Alza CorporationA time release dosage form comprising a semipermeable wall in contact with a therapeutic drug granules coated with polyoxyalkylene glycol
US6001390 *18 déc. 199614 déc. 1999Alza CorporationFormulations for transdermal delivery of pergolide
US6007837 *3 févr. 199928 déc. 1999Alza CorporationHeating device comprising drug-supersaturated first layer and drug-free second layer to cause controlled drug migration from first layer into second layer, rapidly cooling to yield supersaturated concentration of drug in both layers
US6068853 *13 oct. 199530 mai 2000Novartis CorporationTemporally controlled drug delivery systems
US6071896 *18 mars 19986 juin 2000Gundersen Clinic, Ltd.Suppression of thromboxane levels by percutaneous administration of aspirin
US6096333 *8 oct. 19971 août 2000Lectec CorporationMethod of forming adhesive patch for applying medication to the skin
US6096334 *14 déc. 19981 août 2000Lectec CorporationAdhesive patch for applying medication to the skin and method
US6110499 *20 juil. 199829 août 2000Alza CorporationPhenytoin therapy
US6126963 *6 juin 19953 oct. 2000Lts Lohmann Therapie-Systeme Gmbh & Co. KgBags for transdermal drug therapy
US6139868 *6 juin 199531 oct. 2000Lts Lohmann Therapie-Systeme Gmbh & Co. KgTransdermal therapeutic system, its use and production process
US6165497 *1 mars 199126 déc. 2000Alza CorporationSubsaturated nicotine transdermal therapeutic system
US61745453 févr. 199916 janv. 2001Alza CorporationDevice for the transdermal administration of testosterone through intact, non-scrotal skin over an administration period
US62038175 juin 199820 mars 2001Alza CorporationReduction of skin reactions caused by transdermal drug delivery
US62387005 mai 199829 mai 2001Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US626497816 déc. 199224 juil. 2001Lts Lohmann Therapie-Systeme Gmbh & Co. KgTransdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis
US626498018 déc. 199524 juil. 2001Lts Lohmann Therapie-Systeme GmbhTransdermal resorption of active substances from supercooled masses of levulic acid
US628759828 mai 199311 sept. 2001Alza CorporationMethod for providing sustained antiepileptic therapy
US634421121 nov. 20005 févr. 2002Lts Lohmann Therapie-Systeme GmbhReleasing drugs to skin having absorption-increasing auxiliary agents; antibiotics, antipyretics, analgesics, anticoagulants, antidiabetic, cardiotonic, antispasmodic, hypotensive, anticholinergenic, antyarrthythmic agents
US634821010 nov. 199919 févr. 2002Alza CorporationMethods for transdermal drug administration
US644045727 mai 199327 août 2002Alza CorporationAdministering venlafaxine antidepressant time-release agent; sustained release
US646922712 mai 200022 oct. 2002Lectec CorporationAntipruritic patch
US651201014 juil. 199728 janv. 2003Alza CorporationFormulations for the administration of fluoxetine
US656944817 oct. 199727 mai 2003Alza CorporationMethod for preventing crystal formation in a dispersion of a liquid in a matrix
US65728797 juin 19953 juin 2003Alza CorporationFormulations for transdermal delivery of pergolide
US659289229 août 200015 juil. 2003Tepha, Inc.Flushable disposable polymeric products
US666029529 sept. 19989 déc. 2003Alza CorporationA pouch containing (a) a transdermal drug delivery device comprising a drug reservoir layer positioned between a release liner and a backing alyer, one of the layer being non-occlusive, (b) oxybutynin as antioxidant and desiccant
US669949723 juil. 19992 mars 2004Alza CorporationPermeation enhancer
US696035329 sept. 20031 nov. 2005Alza CorporationFormulations for the transdermal administration of fenoldopam
US701184422 nov. 200214 mars 2006Alza CorporationFormulations for the administration of fluoxetine
US706385918 sept. 200220 juin 2006Noven Pharmaceuticals, Inc.Barrier film lined backing layer composition and method for topical administration of active agents
US709442220 août 200322 août 2006Acrux Dds Pty Ltd.With dermal penetration enhancer, octyl salicylate
US71694098 sept. 200330 janv. 2007Alza CorporationHeating film or laminate of a transdermal delivery device which comprises a dispersion of liquid drug in a matrix immediately following film formation or lamination; maintaining heat; cooling
US735789130 janv. 200415 avr. 2008Monosol Rx, LlcProcess for making an ingestible film
US742529214 févr. 200216 sept. 2008Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US755392326 oct. 200730 juin 2009Metabolix, Inc.Medical devices and applications of polyhydroxyalkanoate polymers
US762213618 juin 200424 nov. 2009Alza CorporationTransparent transdermal nicotine delivery devices
US764182529 juil. 20055 janv. 2010Tepha, Inc.Method of making a polyhydroxyalkanoate filament
US766633728 mai 200423 févr. 2010Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US782458814 avr. 20082 nov. 2010Monosol Rx, LlcWater degradation; controlled drying; digestible film containing water soluble polymer
US7833208 *29 déc. 200416 nov. 2010Kimberly-Clark Worldwide, Inc.Multilayer absorbent article
US788348718 déc. 20088 févr. 2011Shantha Totada RTransdermal local anesthetic patch with injection port
US791064114 déc. 200622 mars 2011Monosol Rx, LlcPH modulated films for delivery of actives
US794368331 oct. 200717 mai 2011Tepha, Inc.Thin bioabsorbable materials; toughness, low modulus, tensile strength; tissue repair, drug delivery and support; solvent casting or melt extrusion continuous production
US797261820 sept. 20075 juil. 2011Monosol Rx, LlcAn edible water-soluble film is provided. The film includes at least one water-soluble polymer, and a foam reducing flavoring agent, wherein the film is free of added anti-foaming or defoaming agents.
US801715022 avr. 200813 sept. 2011Monosol Rx, LlcPolyether combined with hydrophilic cellulosic material; demonstrates non-self-aggregating, uniform heterogeneity; mucosally adhesive water soluble product containing analgesic opiate; preventing air pocket formation during production
US801759816 mai 200713 sept. 2011Knopp Neurosciences, Inc.Compositions of R(+) and S(−) pramipexole and methods of using the same
US802625410 nov. 200927 sept. 2011Purdue Pharma, L.P.Therapeutic agents useful for treating pain
US803427030 avr. 200411 oct. 2011Tepha, Inc.Absorbable polyesters; surgery meshes
US807591120 août 200713 déc. 2011Alza CorporationTransparent transdermal nicotine delivery devices
US808405915 sept. 200627 déc. 2011Alza CorporationAntidepressant dosage form
US808412511 déc. 200927 déc. 2011Tepha, Inc.Non-curling polyhydroxyalkanoate sutures
US815316227 sept. 200610 avr. 2012Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US818284027 sept. 200622 mai 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US818284127 sept. 200622 mai 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US818763927 sept. 200629 mai 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US82359299 juil. 20097 août 2012Griffin Santea BMethod of treating pruritis
US82362886 janv. 20127 août 2012Skinmedica, Inc.Melanin modification compositions and methods of use
US824166221 déc. 200614 août 2012Watson Laboratories, Inc.Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
US827336126 sept. 200725 sept. 2012Infectious Disease Research InstituteGlucopyranosyl lipid adjuvant; toll-like receptors; saponins; kits
US8317762 *10 nov. 200827 nov. 2012Nurman SalimSkin patch for absorbing toxins from the body
US832973427 juil. 200911 déc. 2012Afgin Pharma LlcTopical therapy for migraine
US834351220 oct. 20111 janv. 2013Infectious Disease Research InstituteTreatment of allergic conditions using a composition containing synthetic adjuvant
US83538887 oct. 201015 janv. 2013Kimberly-Clark Worldwide, Inc.Multilayer absorbent article
US836127227 juin 200729 janv. 2013Ferring B.V.Polyurethane elastomers
US83612736 sept. 201229 janv. 2013Ferring B.V.Polyurethane elastomers
US83779795 déc. 200619 févr. 2013Taro Pharmaceuticals North America, Inc.Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
US838314922 sept. 200626 févr. 2013Alza CorporationHigh enhancer-loading polyacrylate formulation for transdermal applications
US842012623 avr. 201216 avr. 2013Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US844023523 avr. 201214 mai 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US84454745 août 201121 mai 2013Knopp Neurosciences, Inc.Compositions of R(+) and S(−) pramipexole and methods of using the same
US845500923 avr. 20124 juin 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US846070726 mars 201211 juin 2013Ferring B.V.Stabilised prostaglandin composition
US84607143 avr. 201211 juin 2013Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US84758327 août 20092 juil. 2013Rb Pharmaceuticals LimitedSublingual and buccal film compositions
US849193428 juil. 200523 juil. 2013Ferring B.V.Stabilised prostaglandin composition
US851892614 déc. 200727 août 2013Knopp Neurosciences, Inc.Compositions and methods of using (R)-pramipexole
US851914814 mars 200827 août 2013Knopp Neurosciences, Inc.Synthesis of chirally purified substituted benzothiazole diamines
US852425415 oct. 20073 sept. 2013Ferring B.V.Bioresorbable polymers
US852469514 mars 20083 sept. 2013Knopp Neurosciences, Inc.Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US855728113 juil. 201015 oct. 2013Ferring B.V.Water-swellable polymers
US8574205 *12 mars 20085 nov. 2013Dbv TechnologiesDevice for the cutaneous application of substances
US859242429 juin 200926 nov. 2013Afgin Pharma LlcTopical regional neuro-affective therapy
US860351410 juil. 200710 déc. 2013Monosol Rx, LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US860911430 août 201217 déc. 2013Infectious Diesease Research InstituteMethods of using a vaccine composition containing synthetic adjuvant
US861417917 juil. 200924 déc. 2013E-Therapeutics PlcAntibacterial combination therapy for the treatment of gram positive bacterial infections
US862879810 août 201214 janv. 2014Ferring B.V.Water-swellable polymers
US863280012 mai 200621 janv. 2014Alza CorporationMultilayer drug delivery system with barrier against reservoir material flow
US865237829 mars 201318 févr. 2014Monosol Rx LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US86636805 déc. 20114 mars 2014Alza CorporationTransparent transdermal nicotine delivery devices
US866368713 mai 20104 mars 2014Monosol Rx, LlcFilm compositions for delivery of actives
US868543726 mars 20091 avr. 2014Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US870948231 mai 201329 avr. 2014Ferring B.V.Stabilised prostaglandin composition
US871571529 oct. 20096 mai 2014Nal Pharmaceuticals Ltd.Dosage form for insertion into the mouth
US87220644 juin 201013 mai 2014Infectious Disease Research InstituteSynthetic glucopyranosyl lipid adjuvants
US875355511 avr. 201117 juin 2014Tepha, Inc.Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US875865716 juil. 201324 juin 2014Tepha, Inc.Process of making polyhydroxyalkanoate medical textiles
US875880825 févr. 201324 juin 2014Alza CorporationMethod of making a high enhancer-loading polyacrylate formulation for transdermal applications
US87651678 sept. 20061 juil. 2014Monosol Rx, LlcUniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110046578 *12 mars 200824 févr. 2011Biry Jean-FrancoisDevice for the cutaneous application of substances
US20120245538 *2 déc. 201027 sept. 2012Michael HorstmannTransdermal Therapeutic System for the Administration of Peptides
USRE32991 *25 juil. 198818 juil. 1989Thermedics, Inc.Drug dispensing wound dressing
USRE379343 févr. 200010 déc. 2002Lts Lohmann Therapie-Systeme AgTransdermal therapeutic system
USRE3958831 oct. 199024 avr. 2007Alza CorporationDelays onset of drug administration; does not deliver an initial burst of drug, less likely to cause irritation; stabilizes an active drug by storing it within a transdermal therapeutic system, in form suitable for storage
DE2647581A1 *21 oct. 197627 avr. 1978Henkel KgaaBlisterpackung
DE3500508A1 *9 janv. 198512 sept. 1985Nitto Electric Ind CoPraeparat zur perkutanen verabreichung von arzneimitteln und verfahren zu dessen herstellung
DE3939703A1 *1 déc. 19896 juin 1991Boehringer Ingelheim KgVerbesserte transdermale applikation von pharmakologisch aktiven verbindungen
DE3939703C2 *1 déc. 19892 juil. 1998Boehringer Ingelheim KgVerbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
DE4421433C1 *18 juin 19948 juin 1995Lohmann Therapie Syst LtsTransdermal therapeutic system for treatment of, e.g., hypertension
DE102013107024A14 juil. 201315 mai 2014Golden Biotechnology CorporationMethoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz
DE102013107025A14 juil. 20133 juil. 2014Golden Biotechnology CorporationMethoden und zusammensetzungen zur behanldung von diabetis
DE102013202928A122 févr. 201329 août 2013Golden Biotechnology CorporationVerfahren und Zusammensetzungen zum Behandeln von Krebsmetastasierung
EP0065370A1 *29 avr. 198224 nov. 1982Smith and Nephew Associated Companies p.l.c.Sterile dressing and preparation thereof
EP0236266A1 *9 févr. 19879 sept. 1987Ciba-Geigy AgDermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof
EP0246385A1 *23 mai 198625 nov. 1987New Mexico Tech Research FoundationTranscutaneous application of nicotine
EP0249343A1 *14 mai 198716 déc. 1987Alza CorporationMoisture activation of transdermal drug delivery system
EP0249475A2 *11 juin 198716 déc. 1987Alza CorporationDelayed percutaneous delivery
EP0250125A2 *3 juin 198723 déc. 1987Smith & Nephew plcDrug delivery device, its preparation and use
EP0259136A21 sept. 19879 mars 1988Alza CorporationTransdermal delivery device having a rate controlling adhesive
EP0273004A2 *16 nov. 198729 juin 1988Ciba-Geigy AgUser-activated therapeutical system
EP0279977A2 *28 sept. 198731 août 1988Alza CorporationTransdermal administration of progesterone, estradiol esters and mixtures thereof
EP0336543A1 *23 févr. 198911 oct. 1989John Mark TuckerOcclusive body for administering a physiologically active substance
EP0498468A1 *23 mai 198612 août 1992New Mexico Tech Research FoundationDevice for transcutaneous application of nicotine
EP1674068A119 févr. 199728 juin 2006Acrux DDS Pty LtdDermal penetration enhancers and drug delivery systems involving same
EP2014282A220 juin 200814 janv. 2009E-Therapeutics plcTreatment of depression
EP2158903A214 déc. 19993 mars 2010ALZA CorporationTransparent Transdermal Nicotine Delivery Devices
EP2201840A128 déc. 200630 juin 2010Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2308480A222 sept. 200613 avr. 2011ALZA CorporationHigh Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
EP2316437A112 mai 20064 mai 2011Alza CorporationMultilayer drug delivery system with barrier against reservoir material flow
EP2443929A128 déc. 200625 avr. 2012Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2508231A215 nov. 200710 oct. 2012E-Therapeutics PlcImidazoles for treating multi-drug resistant bacterial infections
EP2526771A128 déc. 200628 nov. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526933A228 déc. 200628 nov. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526934A228 déc. 200628 nov. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529621A128 déc. 20065 déc. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529622A128 déc. 20065 déc. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529733A118 juil. 20085 déc. 2012E-Therapeutics PlcAntibacterial combination therapy
EP2529737A118 juil. 20085 déc. 2012E-Therapeutics plcAntibacterial combination therapy
EP2530083A128 déc. 20065 déc. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532234A128 déc. 200612 déc. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532235A128 déc. 200612 déc. 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2650294A112 oct. 201016 oct. 2013Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2664337A127 sept. 200620 nov. 2013TissueTech, Inc.Amniotic membrane preparations and purified compositions and methods of use
WO1986000532A1 *7 juil. 198430 janv. 1986Flexcon Co IncSilicone pressure sensitive adhesive and uses
WO1987003477A1 *12 déc. 198518 juin 1987Flexcon Co IncTransdermal methods and adhesives
WO1989007959A1 *23 févr. 19898 sept. 1989John Mark TuckerOcclusive body for administering a physiologically active substance
WO1991006270A1 *31 oct. 198916 mai 1991Watson Lab IncMucoadhesive buccal dosage forms
WO1993012799A1 *16 déc. 19928 juil. 1993Lohmann Therapie Syst LtsTransdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
WO1994018966A1 *5 févr. 19941 sept. 1994Fritz HerrmannTransdermal therapeutic system with active substances which represent sources of nitrogen oxide
WO1995035105A1 *3 juin 199528 déc. 1995Lohmann Therapie Syst LtsTransdermal therapeutic system with active substances constituting sources of carbon monoxide
WO2004105854A1 *3 juin 20049 déc. 2004Ilya KaplounDevice and method for dispensing medication to tissue lining a body cavity
WO2007035939A222 sept. 200629 mars 2007Alza CorpHigh enhancer-loading polyacrylate formulation for transdermal applications
WO2007062266A228 nov. 200631 mai 2007Marinus PharmaceuticalsGanaxolone formulations and methods for the making and use thereof
WO2008021368A213 août 200721 févr. 2008Norman HaugheyCompositions and methods for neuroprotection
WO2008066899A228 nov. 20075 juin 2008Marinus PharmaceuticalsNanoparticulate formulations and methods for the making and use thereof
WO2009013480A218 juil. 200829 janv. 2009E Therapeutics PlcAntibacterial combination therapy
WO2010071866A219 déc. 200924 juin 2010Nuon Therapeutics, Inc.Combination therapy for arthritis with tranilast
WO2011030106A110 sept. 201017 mars 2011E-Therapeutics PlcCancer cell apoptosis
WO2012046006A27 oct. 201112 avr. 2012University Of DundeeCancer targets
WO2012104589A12 févr. 20129 août 2012University Of EdinburghWeight related disorders
WO2013160645A126 avr. 201331 oct. 2013E-Therapeutics PlcDexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
WO2013164561A13 mai 20137 nov. 2013E-Therapeutics PlcTramadol for treating depression
Classifications
Classification internationaleA61L15/58, A61M31/00, A61L15/16, A61M37/00, A61F9/00, A61K9/70
Classification coopérativeA61F9/0017, A61M31/002, A61K9/7084, A61M37/00, A61L15/58
Classification européenneA61F9/00B2, A61M31/00D, A61M37/00, A61L15/58, A61K9/70E2D
Événements juridiques
DateCodeÉvénementDescription
23 nov. 1982B1Reexamination certificate first reexamination